The implications and strategic relevance of pricing and market access reform in the US and Europe
Organization: SMi Group
|Event Date/Time: Dec 13, 2012 / 1:00 pm - (GMT)||End Date/Time: Dec 13, 2012 / 4:35 pm - (GMT)|
Developing an effective pricing strategy is an imperative factor in the success and overall profit of a pharmaceutical product. SMi Group’s timely masterclass provides the ideal platform to improve understanding of the current and evolving pricing strategies in the context of the evolving payer environment. The event will provide a unique opportunity to understand and analyse the effects of HTA development from a payer perspective across Europe and the US, as well as learning how to plan and develop effective and effective pricing strategies taking into account recent healthcare reforms including AMNOG in Germany, the Affordable Care Act in the US and value-based pricing in the UK.